Table of Contents As filed with the U.S. Securities and Exchange Commission on December 1, 2025. No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Kestra Medical Technologies, Ltd. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Bermuda 3841 Not Applicable (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...

Core Insights - Kestra Medical Technologies, Ltd. has appointed Dr. Elizabeth Kwo as an independent director to its board, enhancing its leadership team with her extensive experience in digital health and patient care [1][2]. Company Overview - Kestra Medical Technologies is a commercial-stage company focused on wearable medical devices and digital healthcare, aiming to improve patient outcomes in cardiovascular disease through innovative monitoring and therapeutic technologies [3]. Leadership Appointment - Dr. Kwo's background includes roles as Chief Commercial Officer at Everly Health, Deputy Chief Clinical Officer at Anthem, and experience in founding multiple venture-backed companies, which positions her well to contribute to Kestra's mission [2][3]. - Dr. Kwo holds an M.D. from Harvard Medical School, an M.P.H. from Harvard T.H. Chan School of Public Health, an M.B.A. from Harvard Business School, and a B.A. from Stanford University, showcasing her strong academic credentials [2]. Strategic Focus - Dr. Kwo expressed her commitment to advancing Kestra's mission in cardiac recovery and improving patient outcomes through innovation, indicating a strategic alignment with the company's goals [3].

Table of Contents As filed with the U.S. Securities and Exchange Commission on February 26, 2025 Registration No. 333-284807 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Kestra Medical Technologies, Ltd. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 3933 Lake Washington B ...

Table of Contents As filed with the U.S. Securities and Exchange Commission on February 10, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Kestra Medical Technologies, Ltd. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Bermuda 3841 Not Applicable (Primary Standard Industrial Classification Code Number) 3933 Lake Washingto ...